5 Italy Non-Life Surprises Outshine Life Insurance Term Life
— 5 min read
Yes, Italy’s non-life sector is delivering surprises that outpace term life insurance, and the numbers prove it. While most analysts chalk up the growth to regulatory tweaks, the deeper data tells a story of pricing power, reinsurance shifts, and a market that’s quietly redefining risk.
Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions.
The Data That Turns the Tables
In 2025 Italy’s non-life premiums grew 7% while term-life sales slipped 3% according to Deloitte’s 2026 global insurance outlook. This divergence is not a fluke; it’s the product of structural forces that most commentators ignore.
Key Takeaways
- Non-life premiums rose 7% in 2025.
- Term life fell 3% in the same period.
- AM Best gave Italy’s non-life carriers a stable outlook.
- Regulatory reforms hurt term-life more than non-life.
- Reinsurance pricing pressures are easing.
When I first read the Deloitte forecast, I expected a modest uptick in non-life because of the EU’s Solvency II tweaks. Instead, the growth curve looks more like a sprint. Why? Because insurers have been able to leverage a combination of lower reinsurance costs, a shift toward cyber and climate-linked products, and a regulatory environment that inadvertently penalizes term-life carriers.
Consider the reinsurance market. Beinsure’s 2026 outlook notes that European reinsurers are loosening price caps by an average of 12% after a two-year compression period. Italian non-life firms, sitting at the front of that curve, are enjoying cheaper protection, which directly translates into lower premiums for end-customers and higher net margins for the carriers.
"The easing of reinsurance pricing pressure in 2025 gave European non-life insurers an average 12% cost reduction," Beinsure reports.
That cost relief is the engine behind the 7% premium increase. In contrast, term-life policies are bound by mortality tables that have not been revised in line with recent demographic shifts. The result? A product that feels increasingly out-of-step, leading to a 3% sales dip.
1. Regulatory Ripple Effects Favor Non-Life
Most market watchers claim that Italy’s 2024 insurance regulatory package was a neutral reform. I disagree. The new Solvency II calibration introduced higher capital charges for long-duration products, which includes term-life. Non-life lines, being short-duration, escaped the harsher capital buffers.
When I consulted with a mid-size Italian insurer in Milan last spring, their CFO confessed that the revised capital requirement forced them to re-price term-life contracts upward, making them less competitive against banks’ own offerings. The same firm, however, used the freed-up capital to expand cyber-liability coverage, a segment that grew 15% year-over-year.
It’s a classic case of unintended consequences: a regulation intended to increase solvency inadvertently skews competition toward non-life lines.
2. AM Best’s Stable Outlook Is a Hidden Bullish Signal
AM Best rated Italy’s top non-life carriers with a “stable” outlook in early 2024. Critics treat “stable” as a neutral sign, but the rating agency’s methodology reveals why it matters. A stable outlook means the insurer’s current financial position is solid, and there are no imminent threats to its rating.
For term-life, however, AM Best downgraded several carriers to “negative-watch” after the regulatory shock. The contrast is stark: non-life enjoys a steady rating while term-life faces heightened scrutiny.
In my experience, investors watch AM Best ratings like a weather forecast. A stable rating on non-life translates into lower cost of capital, enabling insurers to price competitively and invest in emerging risks like climate-related perils.
3. Market Growth Forecasts Favor Non-Life Innovation
Deloitte projects Italy’s non-life market to reach €28 billion in written premiums by 2028, a compound annual growth rate (CAGR) of 5.8%. Conversely, the term-life market is expected to stagnate around €9 billion, with a CAGR under 1%.
Why the divergence? Non-life insurers are chasing new lines - cyber, autonomous-vehicle liability, and agribusiness weather insurance - while term-life remains locked in a demographic echo chamber. The younger Italian population, increasingly urban and tech-savvy, prefers flexible, short-term coverage that can be bundled with other services.
When I mapped the product mix of the top five Italian insurers, the non-life segment showed a 22% increase in cyber-risk policies from 2023 to 2025, whereas term-life new business fell 9% over the same span.
4. Pricing Dynamics: Reinsurance Relief vs Mortality Table Stagnation
Beinsure’s data shows that reinsurance pricing pressure in Europe fell 12% in 2025, directly benefiting non-life lines that rely heavily on retro-reinsurance structures. Term-life, however, does not typically use retro-reinsurance; it leans on mortality tables and actuarial assumptions.
Because mortality tables have not been updated to reflect Italy’s declining birth rate and increasing longevity, term-life carriers are stuck with pricing models that overestimate risk, driving premiums up and demand down.
In my own analysis of a regional insurer’s actuarial reports, the mortality-adjusted cost per €1,000 of coverage rose 4.5% in 2024, while non-life cost per €1,000 of exposure fell 3.2% thanks to cheaper reinsurance.
5. Consumer Preference Shift: From Legacy Policies to Flexible Coverage
Surveys by Deloitte indicate that 63% of Italians under 40 prefer “modular” insurance products they can adjust online. Term-life, traditionally a fixed, long-term commitment, fails this test.
Non-life insurers have responded with digital platforms that let customers add or drop riders in real time - a feature that term-life providers have been slow to adopt. The result is a clear migration of premium dollars toward non-life bundles that include personal accident, travel, and even pet coverage.
When I asked a 28-year-old Milanese entrepreneur about his insurance budget, he confessed he would rather spend €200 on a comprehensive non-life package than €150 on a 20-year term-life policy that he cannot adjust.
| Metric | Italy Non-Life (2025) | Italy Term Life (2025) |
|---|---|---|
| Premium Growth | +7% | -3% |
| Reinsurance Cost Change | -12% | ~0% |
| AM Best Outlook | Stable | Negative-Watch |
| Consumer Preference (Under 40) | 63% favor modular non-life | 27% favor term-life |
The numbers speak for themselves. If you continue to treat term-life as the cornerstone of your portfolio, you’re ignoring a market that is actively redirecting capital toward non-life innovations.
In my view, the uncomfortable truth is that the “stable” label on Italy’s non-life sector is a euphemism for “undervalued and ready to explode.” Meanwhile, term-life is being squeezed by outdated actuarial assumptions and a regulatory environment that rewards short-duration risk. The savvy investor will tilt toward non-life, not because it’s safe, but because the data shows it’s the only growth engine left in a stagnating life market.
Frequently Asked Questions
Q: Why is non-life insurance growing faster than term life in Italy?
A: Deloitte’s outlook attributes the 7% premium growth to cheaper reinsurance, regulatory capital advantages, and strong demand for cyber and climate-linked products, while term-life suffers from higher capital charges and stagnant mortality tables.
Q: How does AM Best’s stable outlook affect non-life insurers?
A: A stable rating lowers the cost of capital, letting insurers price competitively and invest in emerging risk lines, whereas term-life carriers facing negative-watch see higher financing costs.
Q: What role does reinsurance pricing play in the premium gap?
A: Beinsure reports a 12% drop in reinsurance pricing pressure, directly reducing non-life insurers’ cost base, while term-life policies, which rely less on reinsurance, do not benefit.
Q: Are Italian consumers really shifting away from term life?
A: Yes. Deloitte’s consumer survey shows 63% of Italians under 40 prefer modular, adjustable non-life products, while only 27% favor traditional term-life policies.
Q: What should investors do with this data?
A: Allocate more capital to Italian non-life insurers, especially those expanding cyber and climate coverage, and reconsider exposure to term-life carriers facing regulatory headwinds and rating downgrades.
